Johnson & Johnson (JNJ) Insider Trading
Over the last 3 months, JNJ insiders made 0 open-market buys and 9 sales, a net sale of -$61.0M (SEC Form 4). Over the last 6 months, 3764 institutions increased and 4095 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
9
Net (3m)
-$61.0M
Insider trades by month Buys Sells
Dec
Jan
Feb
Jun
Jul
Aug
Context3-month price +18%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Taubert Jennifer Lofficer: EVP, WWC. Innovative Medicine | Option | 15,000 | $115.67 |
| Aug 18, 2026 | Taubert Jennifer Lofficer: EVP, WWC. Innovative Medicine | Sell | 15,000 | $263.36 |
| Aug 14, 2026 | Duato Joaquindirector, officer: CEO and Chairman of the Board | Sell | 20,976 | $262.00 |
| Aug 14, 2026 | Duato Joaquindirector, officer: CEO and Chairman of the Board | Option | 123,291 | $115.67 |
| Aug 14, 2026 | Duato Joaquindirector, officer: CEO and Chairman of the Board | Sell | 102,315 | $261.00 |
| Aug 7, 2026 | Forminard Elizabethofficer: EVP, Chief Legal Officer | Option | 9,344 | $131.94 |
| Aug 7, 2026 | Forminard Elizabethofficer: EVP, Chief Legal Officer | Sell | 6,574 | $255.93 |
| Aug 7, 2026 | Duato Joaquindirector, officer: CEO and Chairman of the Board | Sell | 41,957 | $258.06 |
| Aug 7, 2026 | Duato Joaquindirector, officer: CEO and Chairman of the Board | Sell | 6,523 | $258.74 |
| Aug 7, 2026 | Forminard Elizabethofficer: EVP, Chief Legal Officer | Sell | 9,344 | $257.75 |
| Jul 21, 2026 | Broadhurst Vanessaofficer: EVP, Global Corp Affairs | Option | 11,925 | $131.94 |
| Jul 21, 2026 | Broadhurst Vanessaofficer: EVP, Global Corp Affairs | Option | 11,129 | $129.51 |
| Jul 21, 2026 | Broadhurst Vanessaofficer: EVP, Global Corp Affairs | Sell | 23,054 | $251.27 |
| Jun 12, 2026 | Wengel Kathryn Eofficer: EVP, Chief TO and Risk Officer | Sell | 10,000 | $241.15 |
| Jun 12, 2026 | Wengel Kathryn Eofficer: EVP, Chief TO and Risk Officer | Option | 10,000 | $115.67 |
| Jun 11, 2026 | Woods Eugene A.director | Grant | 161 | — |
| Jun 11, 2026 | Pinto Daniel Edirector | Grant | 134 | — |
| Jun 11, 2026 | HEWSON MARILLYN Adirector | Grant | 215 | — |
| May 4, 2026 | REED JOHN Cofficer: EVP, Innovative Medicine, R&D | Option | 25,255 | — |
| May 4, 2026 | REED JOHN Cofficer: EVP, Innovative Medicine, R&D | Tax | 11,002 | $229.85 |
| Apr 27, 2026 | Beckerle Mary Cdirector | Grant | 975 | — |
| Apr 27, 2026 | HEWSON MARILLYN Adirector | Grant | 975 | — |
| Apr 27, 2026 | Johnson Paula Adirector | Grant | 975 | — |
| Apr 27, 2026 | Doudna Jennifer Adirector | Grant | 975 | — |
| Apr 27, 2026 | McClellan Mark B.director | Grant | 975 | — |
| Apr 27, 2026 | MORIKIS JOHN Gdirector | Grant | 1,540 | — |
| Apr 27, 2026 | West Nadjadirector | Grant | 975 | — |
| Apr 27, 2026 | Woods Eugene A.director | Grant | 975 | — |
| Apr 27, 2026 | Joly Hubertdirector | Grant | 975 | — |
| Apr 27, 2026 | Pinto Daniel Edirector | Grant | 1,712 | — |
Source: JNJ SEC Form 4 filings, latest Aug 18, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their JNJ positions over the last 6 months (SEC Form 13F).
Increased
3764
New positions
554
Reduced
4095
Sold out
130
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 213.4M | May 13, 2026 |
| BlackRock, Inc. | Reduced | 212.1M | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 157.2M | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 156.6M | May 15, 2026 |
| STATE STREET CORP | Increased | 133.8M | Aug 7, 2026 |
| STATE STREET CORP | Reduced | 133.5M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 64.4M | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 63.5M | May 8, 2026 |
| JPMORGAN CHASE & CO | Increased | 63.1M | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 59.2M | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 59.1M | Aug 12, 2026 |
| JPMORGAN CHASE & CO | Reduced | 58.3M | Aug 12, 2026 |
| MORGAN STANLEY | Increased | 44.8M | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 44.7M | May 15, 2026 |
| NORGES BANK | New Position | 31.8M | Aug 12, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.